Stock Report

Download full stock data and analysis for free Last Updated: 09-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Dr. Reddy's Laboratories - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$14.91

up-down-arrow $0.38 (2.62%)

As on 06-Nov-2026 16:12EST

Market cap

info icon

$12,113 Mln

Revenue (TTM)

info icon

$331,377 Mln

P/E Ratio

info icon

40.4

P/B Ratio

info icon

2.9

Div. Yield

info icon

0.6 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 6.66 -1.65 -3.15 34.34 27.10
EBIT 299.74 -38.32 -59.13 -4.52 13.97
Net Profit 105.66 -35.38 -51.78 2.00 36.10
EPS 106.90 -35.75 -52.16 -28.53 32.37
Book Value -- -- 10.79 16.86 174.37
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 22.7521.789.7917.4324.46
Net Margin info ----8.46----
Return on equity info 17.6719.777.5112.8318.42
Return on Capital info 15.9917.59--10.9216.61
Return on Assets info 12.3513.523.938.5012.84
Debt to Equity (x) info ----0.030.210.14

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
10.92
16.61
20.43
19.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

7.51

Lower than Peers by 12.46

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
7.51
12.83
18.42
21.77
21.38
Peer Median
19.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

3.93

Higher than Peers by 1.02

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
3.93
8.50
12.84
15.70
14.66
Peer Median
2.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

9.79

Lower than Peers by 5.34

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
9.79
17.43
24.46
26.36
25.13
Peer Median
15.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

8.46

Higher than Peers by 0.12

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
8.46
12.76
17.37
19.95
18.33
Peer Median
8.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-3.15

Lower than Peers by 11.95

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-3.15
0.09
0.17
0.14
0.15
Peer Median
8.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-59.13

Lower than Peers by 69.25

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-59.13
-22.61
8.20
19.07
85.82
Peer Median
10.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-51.78

Lower than Peers by 61.48

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-51.78
-20.26
1.54
23.56
91.22
Peer Median
9.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-52.16

Lower than Peers by 64.04

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-52.16
-0.20
0.02
0.23
0.91
Peer Median
11.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

8.16

Higher than Peers by 1.59

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
8.16
--
--
--
--
Peer Median
6.57
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.03

Lower than Peers by 0.46

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
0.03
0.21
0.14
0.07
0.06
Peer Median
0.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.16

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
0.16
0.17
0.12
0.05
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.93

Higher than Peers by 0.23

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
1.93
1.80
1.92
2.58
2.38
Peer Median
1.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.40

Higher than Peers by 0.13

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
1.40
1.35
1.37
1.92
1.81
Peer Median
1.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

8.78

Higher than Peers by 2.48

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
8.78
15.66
28.14
43.00
43.27
Peer Median
6.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

30.73

Higher than Peers by 9.37

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
30.73
28.07
33.73
34.15
33.84
Peer Median
21.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.46

Higher than Peers by 0.05

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
0.46
0.67
0.74
0.79
0.80
Peer Median
0.42
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
107.99
115.08
116.80
121.42
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
159.82
181.99
177.35
170.66
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
57.76
56.23
62.27
57.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
210.04
240.84
231.88
234.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month